Insights from 2023 EHA® Annual Meeting

 

Insights from 2023 EHA® Annual Meeting
A

Updated Data for Ziftomenib in Adults With NPM1-Mutated R/R AML

By Insights from 2023 EHA® Annual Meeting FEATURING Amir Fathi
By Insights from 2023 EHA® Annual Meeting FEATURING Amir Fathi
241 views
August 8, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison
Leukemia
10:42

Updated Data for Ziftomenib in Adults With NPM1-Mutated R/R AML

Insights from 2023 EHA® Annual Meeting

A. Fathi

241 views
16:16

Experts Discuss Key Updates in CLL From EHA and iCML

Insights from 2023 EHA® Annual Meeting

S. O'Brien, C. Coombs

446 views
06:28

EHA® 2023 Insights: "Venetoclax + Obinutuzumab for Previously Untrea…

Insights from 2023 EHA® Annual Meeting

O. Al-Sawaf

670 views
07:51

EHA® 2023 Insights: "4-Year Follow-Up From the Randomized Phase 2 VI…

Insights from 2023 EHA® Annual Meeting

A. Kater

82 views